Kalaris Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KLRS and other ETFs, options, and stocks.About KLRS
Kalaris Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing and commercializing innovative therapeutics for retinal diseases. It is focusing on developing TH103, a novel anti-VEGF agent targeted at treating neovascular and exudative retinal diseases.
KLRS Key Statistics
Stock Snapshot
As of today, Kalaris Therapeutics(KLRS) shares are valued at $5.82. The company's market cap stands at 132.98M, with a P/E ratio of -1.39.
On 2026-04-14, Kalaris Therapeutics(KLRS) stock traded between a low of $5.66 and a high of $6.37. Shares are currently priced at $5.82, which is +2.8% above the low and -8.6% below the high.
Kalaris Therapeutics(KLRS) shares are trading with a volume of 140.03K, against a daily average of 80K.
During the past year, Kalaris Therapeutics(KLRS) stock moved between $2.14 at its lowest and $11.88 at its peak.
During the past year, Kalaris Therapeutics(KLRS) stock moved between $2.14 at its lowest and $11.88 at its peak.
KLRS News
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.